Answer
Clinically significant interactions with other medicines have neither been reported during Rekovelle (follitropin delta) therapy nor are expected, although no interaction studies have been performed.
Sources for this answer
- REKOVELLE 12 micrograms/0.36 mL solution for injection in a pre-filled penFerring Pharmaceuticals Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked